Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension

References

• QuigleyHABromanATThe number of people with glaucoma world-wide in 2010 and 2020Br J Ophthalmol200690326226716488940
   PubMed Web of Science ®Google Scholar
• TsaiJCA comprehensive perspective on patient adherence to topical glaucoma therapyOphthalmology200911611 SupplS30S3619837258
   PubMed Web of Science ®Google Scholar
• RheeDJRapuanoCJPapaliodisGNFraunfelderFWPhysicians’ Desk Reference for Ophthalmic Medicines39th edMontvale, NJPDR Network, LLC2010
   Google Scholar
• AllinghamRRDamjiKFFreedmanSMoroiSEShafranovGShieldsMBShields’ Textbook of Glaucoma5th edPhiladelphia, PALippincott Williams and Wilkins2005
   Google Scholar
• WhiteCJByrneMEMolecularly imprinted therapeutic contact lensesExpert Opin Drug Deliv20107676578020408742
   PubMed Web of Science ®Google Scholar
• SinghVBushettiSSAppalaRShareefAImamSSSinghMStimuli- sensitive hydrogels: A novel ophthalmic drug delivery systemIndian J Ophthalmol20105847748120952830
   PubMed Web of Science ®Google Scholar
• Hui-HuiAQiu-HuaLZhi-JunYWei-SanPShu-FangNNovel ophthalmic timolol maleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivoDrug Delivery Epub 2011, May 1 Available from informahealthcare.comAccessed August 15, 2011
   Google Scholar
• XuJXinsongLFuqianSIn vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug deliveryDrug Deliv201118215015821043996
   PubMed Web of Science ®Google Scholar
• TsaiJCForbesMMedical Management of Glaucoma3rd edCaddo, OKProfessional Communications Inc2009
   Google Scholar
• ShaarawyTSherwoodMBHitchingsRACrowstonJGGlaucoma: Medical Diagnosis and Therapy1Beijing, ChinaElsevier Limited2009
   Google Scholar
• MarchWFOchsnerKIThe long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study GroupAm J Ophthalmol2000129213614310682964
   PubMed Web of Science ®Google Scholar
• SilverLHClinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study GroupAm J Ophthalmol199812634004089744373
   PubMed Web of Science ®Google Scholar
• MichaudJEFrirenBComparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertensionAm J Ophthalmol2001132223524311476685
   PubMed Web of Science ®Google Scholar
• KabackMScoperSVArzenoGIntraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%Ophthalmology2008115101728173418538406
   PubMed Web of Science ®Google Scholar
• ManniGDenisPChewPThe safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionJ Glaucoma200918429330019365194
   PubMed Web of Science ®Google Scholar
• HolloGBozkurtBIrkecMBrinzolamide/timolol fixed combination: A new ocular suspension for the treatment of open-angle glaucoma and ocular hypertensionExpert Opin Pharmacother200910122015202419618994
   PubMed Web of Science ®Google Scholar
• TsukamotoHNomaHMatsuyamaSIkedaHMishimaHKThe efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucomaJ Ocul Pharmacol Ther200521217017315857284
   PubMed Web of Science ®Google Scholar
• GoldbergICrowstonJGJasekMCStewartJAStewartWCIntraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapyJ GlaucomaNovember 22010 [Epub ahead of print]
   Web of Science ®Google Scholar
• HolloGKothyPIntraocular pressure reduction with travoprost/ timolol fixed combination, with and without adjunctive brinzolamide, in glaucomaCurr Med Res Opin20082461755176118479590
   PubMed Web of Science ®Google Scholar
• SieskyBHarrisACantorLBA comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucomaBr J Ophthalmol200892450050418369067
   PubMed Web of Science ®Google Scholar
• SieskyBHarrisABrizendineELiterature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flowSurv Ophthalmol2009541334619171209
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyEuropean Public Assessment Report (EPAR): Azarga Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000960/WC500029824.pdfAccessed January 19, 2011
   Google Scholar
• KannerETsaiJCGlaucoma medications: Use and safety in the elderly populationDrugs Aging200623432133216732691
   PubMed Web of Science ®Google Scholar
• BartlettJDOphthalmic Drug FactsSt Louis, MOFacts and Comparisons2003
   Google Scholar
• HolloGBrinzolamide/timolol fixed combination for open-angle glaucoma and ocular hypertensionExp Rev Ophthalmol200942129133
   Google Scholar
• SchmierJKHalpernMTJonesMLThe economic implications of glaucoma: A literature reviewPharmacoeconomics200725428730817402803
   PubMed Web of Science ®Google Scholar
• JuzychMSRandhawaSShukairyAKaushalPGuptaAShalautaNFunctional health literacy in patients with glaucoma in urban settingsArch Ophthalmol2008126571872418474786
   PubMedGoogle Scholar
• MuirKWSantiago-TurlaCStinnettSSHealth literacy and adherence to glaucoma therapyAm J Ophthalmol2006142222322616876500
   PubMed Web of Science ®Google Scholar
• BarnebeyHKwokSYPatients’ acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice settingClin Ther200022101204121211110231
   PubMed Web of Science ®Google Scholar
• StewartWCDayDGStewartJAHolmesKTJenkinsJNShort-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjectsEye (Lond)200418990591015002017
   PubMed Web of Science ®Google Scholar
• SilverLHOcular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: Results from two multicenter comfort studies. Brinzolamide Comfort Study GroupSurv Ophthalmol200044Suppl 2S141S14510665516
   PubMed Web of Science ®Google Scholar
• MundorfTKRauchmanSHWilliamsRDNotivolRA patient preference comparison of Azarga (brinzolamide/timolol fixed combination) vs Cosopt (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol200823623819668763
   PubMedGoogle Scholar
• VoldSDEvansRMStewartRHWaltersTMallickSA one-week comfort study of BID-dosed brinzolamide 1%/timolol 0.5% ophthalmic suspension fixed combination compared to BID-dosed dorzolamide 2%/timolol 0.5% ophthalmic solution in patients with open-angle glaucoma or ocular hypertensionJ Ocul Pharmacol Ther200824660160519049301
   PubMed Web of Science ®Google Scholar
• Merck Sharp and Dohme Corporation Available from: http://www.merck.com/product/usa/pi_circulars/c/cosopt/cosopt_pi.pdfAccessed February 7, 2011
   Google Scholar